المؤلفون: Schnell, O, Barnard-Kelly, K, Battelino, T, Ceriello, A, Larsson, HE, Fernandez-Fernandez, B, Forst, T, Frias, JP, Gavin, JR, Giorgino, F, Groop, PH, Heerspink, HJL, Herzig, S, Hummel, M, Huntley, G, Ibrahim, M, Itzhak, B, Jacob, S, Ji, LN, Kosiborod, M, Lalic, N, Macieira, S, Malik, RA, Mankovsky, B, Marx, N, Mathieu, C, Mueller, TD, Ray, K, Rodbard, HW, Rossing, P, Ryden, L, Schumm-Draeger, PM, Schwarz, P, Skrha, J, Snoek, F, Tacke, F, Taylor, B, Jeppesen, BT, Tesfaye, S, Topsever, P, Vilsboll, T, Yu, XF, Standl, E

المصدر: Cardiovascular diabetology. 23(1):104

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:155309291

المؤلفون: Frias, JP, Domingo, MP, Meneghini, L, Napoli, R, Liu, M, Rak, ES, Aroda, VR

المصدر: Diabetologia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::973239b498e35f0633114a349109e677
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7500

المؤلفون: Megson, IL, Treweeke, AT, Shaw, Andrew, MacRury, SM, Setford, S, Frias, JP, Anhalt, H

المصدر: Journal of Diabetes Science and Technology

مصطلحات موضوعية: C990

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::61c83fde764128bed960095e8d119c6a

المؤلفون: DeFronzo RA; University of Texas Health Science Center, San Antonio, Texas, USA., Auchus RJ; Departments of Pharmacology and Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, Michigan, USA., Bancos I; Division of Endocrinology, Mayo Clinic, Rochester, Minnesota, USA., Blonde L; Ochsner Diabetes Clinical Research Unit, Frank Riddick Diabetes Institute, Endocrinology Department, Ochsner Health, New Orleans, Louisiana, USA., Busch RS; Albany Medical College: Community Endocrine Group, Albany, New York, USA., Buse JB; The University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Findling JW; Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Fonseca VA; Section of Endocrinology, Department of Medicine, Tulane University, New Orleans, Louisiana, USA., Frias JP; Velocity Clinical Research, Los Angeles, California, USA., Hamidi O; The University of Texas Southwestern Medical Center, Dallas, Texas, USA., Handelsman Y; Metabolic Institute of America, Tarzana, California, USA., Pratley RE; AdventHealth Translational Research Institute, Orlando, Florida, USA., Rosenstock J; Velocity Clinical Research, Dallas, Texas, USA., Tudor IC; Corcept Therapeutics Incorporated, Menlo Park, California, USA., Moraitis AG; Corcept Therapeutics Incorporated, Menlo Park, California, USA., Einhorn D; Corcept Therapeutics Incorporated, Menlo Park, California, USA deinhorn@corcept.com.

المصدر: BMJ open [BMJ Open] 2024 Jul 16; Vol. 14 (7), pp. e081121. Date of Electronic Publication: 2024 Jul 16.

نوع المنشور: Journal Article; Clinical Trial Protocol; Multicenter Study

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Cushing Syndrome*/drug therapy , Mifepristone*/therapeutic use, Humans ; Prospective Studies ; Prevalence ; Female ; Male ; Hormone Antagonists/therapeutic use ; Multicenter Studies as Topic ; Middle Aged ; Adult ; Glycated Hemoglobin/analysis ; Glycated Hemoglobin/metabolism ; Hydrocortisone/blood ; Double-Blind Method

المؤلفون: Sanyal AJ; Stravitz-Sanyal Institute for Liver Disease and Metabolic Health and Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. arun.sanyal@vcuhealth.org., Kaplan LM; Section of Obesity Medicine and Weight and Wellness Center, Geisel School of Medicine at Dartmouth, Hanover, NH, USA., Frias JP; Velocity Clinical Research, Los Angeles, CA, USA., Brouwers B; Eli Lilly and Company, Indianapolis, IN, USA., Wu Q; Eli Lilly and Company, Indianapolis, IN, USA., Thomas MK; Eli Lilly and Company, Indianapolis, IN, USA., Harris C; Eli Lilly and Company, Indianapolis, IN, USA., Schloot NC; Lilly Deutschland GmbH, Bad Homburg, Germany., Du Y; Eli Lilly and Company, Indianapolis, IN, USA., Mather KJ; Eli Lilly and Company, Indianapolis, IN, USA., Haupt A; Eli Lilly and Company, Indianapolis, IN, USA., Hartman ML; Eli Lilly and Company, Indianapolis, IN, USA.

المصدر: Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2037-2048. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Fatty Liver*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Adult ; Double-Blind Method ; Receptors, Glucagon/agonists ; Glucagon-Like Peptide-1 Receptor/agonists ; Liver/drug effects ; Liver/metabolism ; Obesity/drug therapy ; Obesity/complications ; Aged ; Fatty Acids ; Peptides

المؤلفون: Frias JP; Velocity Clinical Research, Los Angeles, CA 90057, USA., De Block C; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, 2650 Edegem, Belgium., Brown K; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Wang H; TechData Service, King of Prussia, PA 19406, USA., Thomas MK; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Zeytinoglu M; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA., Maldonado JM; Lilly Research Laboratories, Eli Lilly and Company, San Juan 00918, Puerto Rico.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jun 17; Vol. 109 (7), pp. 1745-1753.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Diabetes Mellitus, Type 2*/metabolism , Insulin Resistance* , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/pharmacology , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/pharmacology , Hypoglycemic Agents*/therapeutic use , Biomarkers*/blood, Humans ; Male ; Female ; Middle Aged ; Glycated Hemoglobin/analysis ; Insulin-Secreting Cells/drug effects ; Insulin-Secreting Cells/metabolism ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Aged ; Adult ; Double-Blind Method ; Insulin/blood ; Insulin/metabolism ; Islets of Langerhans/drug effects ; Islets of Langerhans/metabolism ; Treatment Outcome ; Glucagon-Like Peptide-2 Receptor ; Gastric Inhibitory Polypeptide

المؤلفون: Harrison SA; University of Oxford, Oxford, United Kingdom; Pinnacle Clinical Research, San Antonio, Texas., Frias JP; Velocity Clinical Research, Los Angeles, California., Lucas KJ; Lucas Research, Morehead, North Carolina., Reiss G; Tandem Clinical Research, Marrero, Louisiana., Neff G; Covenant Metabolic Specialists, LLC, Sarasota, Florida; Covenant Research and Clinics LLC, Ft. Myers, Florida., Bollepalli S; Tampa Bay Medical Research, Clearwater, Florida., Su Y; Medpace, Cincinnati, Ohio., Chan D; Akero Therapeutics Inc, South San Francisco, California., Tillman EJ; Akero Therapeutics Inc, South San Francisco, California., Moulton A; Akero Therapeutics Inc, South San Francisco, California., de Temple B; Akero Therapeutics Inc, South San Francisco, California., Zari A; Akero Therapeutics Inc, South San Francisco, California., Shringarpure R; Akero Therapeutics Inc, South San Francisco, California. Electronic address: reshma@akerotx.com., Rolph T; Akero Therapeutics Inc, South San Francisco, California., Cheng A; Akero Therapeutics Inc, South San Francisco, California., Yale K; Akero Therapeutics Inc, South San Francisco, California.

المصدر: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Mar 04. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-7714 (Electronic) Linking ISSN: 15423565 NLM ISO Abbreviation: Clin Gastroenterol Hepatol Subsets: MEDLINE

المؤلفون: Sohn M; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea., Frias JP; National Research Institute, Metro Medical Mall, Los Angeles, California, USA., Lim S; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Dec; Vol. 25 (12), pp. 3560-3577. Date of Electronic Publication: 2023 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Diabetes Mellitus, Type 2*/complications , Thiazolidinediones*/adverse effects , Dipeptidyl-Peptidase IV Inhibitors*/adverse effects , Heart Failure*/prevention & control , Heart Failure*/complications , Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/prevention & control , Cardiovascular Diseases*/etiology, Humans ; Hypoglycemic Agents/adverse effects ; Network Meta-Analysis ; Randomized Controlled Trials as Topic ; Glucagon-Like Peptide 1/therapeutic use ; Glucose/therapeutic use ; Glucagon-Like Peptide-1 Receptor/agonists

المؤلفون: Harrison SA; Department of Hepatology, University of Oxford, Oxford, UK; Pinnacle Clinical Research, San Antonio, TX, USA., Frias JP; Velocity Clinical Research, Los Angeles, CA, USA., Neff G; Covenant Metabolic Specialists, Sarasota, FL, USA., Abrams GA; Department of Medicine, Prisma Health Upstate, Greenville, SC, USA., Lucas KJ; Lucas Research, Morehead, NC, USA., Sanchez W; Floridian Clinical Research, Miami Lakes, FL, USA., Gogia S; Texas Digestive Disease Institute, Webster, TX, USA., Sheikh MY; Fresno Clinical Research Center, Fresno, CA, USA., Behling C; Department of Pathology, Sharp Memorial Hospital, San Diego, CA, USA., Bedossa P; Liverpat, Paris, France; Institute of Cellular Medicine, University of Newcastle, Newcastle upon Tyne, UK., Shao L; Statistics, Labcorp, Burlington, NC, USA., Chan D; Akero Therapeutics, South San Francisco, CA, USA., Fong E; Akero Therapeutics, South San Francisco, CA, USA., de Temple B; Akero Therapeutics, South San Francisco, CA, USA., Shringarpure R; Akero Therapeutics, South San Francisco, CA, USA. Electronic address: reshma@akerotx.com., Tillman EJ; Akero Therapeutics, South San Francisco, CA, USA., Rolph T; Akero Therapeutics, South San Francisco, CA, USA., Cheng A; Akero Therapeutics, South San Francisco, CA, USA., Yale K; Akero Therapeutics, South San Francisco, CA, USA.

مؤلفون مشاركون: HARMONY Study Group

المصدر: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2023 Dec; Vol. 8 (12), pp. 1080-1093. Date of Electronic Publication: 2023 Oct 03.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Non-alcoholic Fatty Liver Disease*/drug therapy , Non-alcoholic Fatty Liver Disease*/pathology, Adult ; Female ; Humans ; Male ; Middle Aged ; Double-Blind Method ; Inflammation ; Liver Cirrhosis ; Treatment Outcome

المؤلفون: Alkhouri N; Arizona Liver Health, Chandler, Arizona, USA., Lazas D; ObjectiveHealth/Digestive Health Research, Nashville, Tennessee, USA., Loomba R; University of California San Diego, San Diego, California, USA., Frias JP; Velocity Clinical Research, Los Angeles, California, USA., Feng S; 89bio Inc., San Francisco, California, USA., Tseng L; 89bio Inc., San Francisco, California, USA., Balic K; 89bio Inc., San Francisco, California, USA., Agollah GD; 89bio Inc., San Francisco, California, USA., Kwan T; 89bio Inc., San Francisco, California, USA., Iyer JS; PathAI Inc., Boston, Massachusetts, USA., Morrow L; Prosciento Inc., San Diego, California, USA., Mansbach H; 89bio Inc., San Francisco, California, USA., Margalit M; 89bio, Rehovot, Israel., Harrison SA; Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Pinnacle Clinical Research, San Antonio, Texas, USA.

المصدر: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Nov; Vol. 58 (10), pp. 1005-1015. Date of Electronic Publication: 2023 Sep 18.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Non-alcoholic Fatty Liver Disease*/drug therapy , Non-alcoholic Fatty Liver Disease*/pathology, Adult ; Humans ; Young Adult ; Middle Aged ; Aged ; Cohort Studies ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/pathology ; Biopsy